NAGE vs NOC · P/E 59, rev $61.3M vs P/E 17, rev $20.76B
Niagen Bioscience, Inc. (NAGE) versus Northrop Grumman Corporation (NOC) — a side-by-side from cached financials, not a winner call.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Latest reported NAGE revenue for 2026-06-30 was $61.3M. Net income was $7.3M. Revenue was up 94.6% from 2026-03-31 to 2026-06-30. NAGE currently screens at market cap $836.5M and trailing P/E 59.0.
Latest reported NOC revenue for 2026-06-30 was $20.76B. Net income was $1.97B. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
NAGE currently screens at market cap $836.5M and trailing P/E 59.0. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
Not investment advice. Open the NAGE and NOC stock pages for the full models.
Not investment advice.